Global Biological Drug CDMO Supply, Demand and Key Producers, 2023-2029
The global Biological Drug CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Biological drug CDMO (Contract Development and Manufacturing Organization) is a company that specializes in the development and manufacturing of biological drugs. Biological drugs are complex molecules that are produced from living cells, and they include a wide range of products such as vaccines, monoclonal antibodies, and cell therapies.
This report studies the global Biological Drug CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biological Drug CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological Drug CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biological Drug CDMO total market, 2018-2029, (USD Million)
Global Biological Drug CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biological Drug CDMO total market, key domestic companies and share, (USD Million)
Global Biological Drug CDMO revenue by player and market share 2018-2023, (USD Million)
Global Biological Drug CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Biological Drug CDMO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Biological Drug CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Samsung Biologics, Lonza, Boehringer Ingelheim, Catalent, BioCentriq, FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific, Recipharm and Delpharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biological Drug CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biological Drug CDMO Market, By Region:
1. How big is the global Biological Drug CDMO market?
2. What is the demand of the global Biological Drug CDMO market?
3. What is the year over year growth of the global Biological Drug CDMO market?
4. What is the total value of the global Biological Drug CDMO market?
5. Who are the major players in the global Biological Drug CDMO market?
6. What are the growth factors driving the market demand?
Biological drug CDMO (Contract Development and Manufacturing Organization) is a company that specializes in the development and manufacturing of biological drugs. Biological drugs are complex molecules that are produced from living cells, and they include a wide range of products such as vaccines, monoclonal antibodies, and cell therapies.
This report studies the global Biological Drug CDMO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biological Drug CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological Drug CDMO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biological Drug CDMO total market, 2018-2029, (USD Million)
Global Biological Drug CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biological Drug CDMO total market, key domestic companies and share, (USD Million)
Global Biological Drug CDMO revenue by player and market share 2018-2023, (USD Million)
Global Biological Drug CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global Biological Drug CDMO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Biological Drug CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Samsung Biologics, Lonza, Boehringer Ingelheim, Catalent, BioCentriq, FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific, Recipharm and Delpharm, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biological Drug CDMO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biological Drug CDMO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Innovative Drug
- Listed Patent Drugs
- Biosimilar
- Pharmaceutical Company
- Biotechnology Company
- Samsung Biologics
- Lonza
- Boehringer Ingelheim
- Catalent
- BioCentriq
- FUJIFILM Diosynth Biotechnologies
- Thermo Fisher Scientific
- Recipharm
- Delpharm
- Aenova
- Siegfried
- WuXi Biologics
- Obio Technology
- Hepalink
- Pharmaron
- ChemPartner
1. How big is the global Biological Drug CDMO market?
2. What is the demand of the global Biological Drug CDMO market?
3. What is the year over year growth of the global Biological Drug CDMO market?
4. What is the total value of the global Biological Drug CDMO market?
5. Who are the major players in the global Biological Drug CDMO market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biological Drug CDMO Introduction
1.2 World Biological Drug CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biological Drug CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Biological Drug CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biological Drug CDMO Market Size (2018-2029)
1.3.3 China Biological Drug CDMO Market Size (2018-2029)
1.3.4 Europe Biological Drug CDMO Market Size (2018-2029)
1.3.5 Japan Biological Drug CDMO Market Size (2018-2029)
1.3.6 South Korea Biological Drug CDMO Market Size (2018-2029)
1.3.7 ASEAN Biological Drug CDMO Market Size (2018-2029)
1.3.8 India Biological Drug CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological Drug CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biological Drug CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biological Drug CDMO Consumption Value (2018-2029)
2.2 World Biological Drug CDMO Consumption Value by Region
2.2.1 World Biological Drug CDMO Consumption Value by Region (2018-2023)
2.2.2 World Biological Drug CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Biological Drug CDMO Consumption Value (2018-2029)
2.4 China Biological Drug CDMO Consumption Value (2018-2029)
2.5 Europe Biological Drug CDMO Consumption Value (2018-2029)
2.6 Japan Biological Drug CDMO Consumption Value (2018-2029)
2.7 South Korea Biological Drug CDMO Consumption Value (2018-2029)
2.8 ASEAN Biological Drug CDMO Consumption Value (2018-2029)
2.9 India Biological Drug CDMO Consumption Value (2018-2029)
3 WORLD BIOLOGICAL DRUG CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Biological Drug CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biological Drug CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biological Drug CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Biological Drug CDMO in 2022
3.3 Biological Drug CDMO Company Evaluation Quadrant
3.4 Biological Drug CDMO Market: Overall Company Footprint Analysis
3.4.1 Biological Drug CDMO Market: Region Footprint
3.4.2 Biological Drug CDMO Market: Company Product Type Footprint
3.4.3 Biological Drug CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biological Drug CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biological Drug CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biological Drug CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biological Drug CDMO Consumption Value Comparison
4.2.1 United States VS China: Biological Drug CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biological Drug CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biological Drug CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Biological Drug CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biological Drug CDMO Revenue, (2018-2023)
4.4 China Based Companies Biological Drug CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Biological Drug CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biological Drug CDMO Revenue, (2018-2023)
4.5 Rest of World Based Biological Drug CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biological Drug CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biological Drug CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biological Drug CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Innovative Drug
5.2.2 Listed Patent Drugs
5.2.3 Biosimilar
5.3 Market Segment by Type
5.3.1 World Biological Drug CDMO Market Size by Type (2018-2023)
5.3.2 World Biological Drug CDMO Market Size by Type (2024-2029)
5.3.3 World Biological Drug CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biological Drug CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.3 Market Segment by Application
6.3.1 World Biological Drug CDMO Market Size by Application (2018-2023)
6.3.2 World Biological Drug CDMO Market Size by Application (2024-2029)
6.3.3 World Biological Drug CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Samsung Biologics
7.1.1 Samsung Biologics Details
7.1.2 Samsung Biologics Major Business
7.1.3 Samsung Biologics Biological Drug CDMO Product and Services
7.1.4 Samsung Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Samsung Biologics Recent Developments/Updates
7.1.6 Samsung Biologics Competitive Strengths & Weaknesses
7.2 Lonza
7.2.1 Lonza Details
7.2.2 Lonza Major Business
7.2.3 Lonza Biological Drug CDMO Product and Services
7.2.4 Lonza Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Lonza Recent Developments/Updates
7.2.6 Lonza Competitive Strengths & Weaknesses
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Details
7.3.2 Boehringer Ingelheim Major Business
7.3.3 Boehringer Ingelheim Biological Drug CDMO Product and Services
7.3.4 Boehringer Ingelheim Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Boehringer Ingelheim Recent Developments/Updates
7.3.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.4 Catalent
7.4.1 Catalent Details
7.4.2 Catalent Major Business
7.4.3 Catalent Biological Drug CDMO Product and Services
7.4.4 Catalent Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Catalent Recent Developments/Updates
7.4.6 Catalent Competitive Strengths & Weaknesses
7.5 BioCentriq
7.5.1 BioCentriq Details
7.5.2 BioCentriq Major Business
7.5.3 BioCentriq Biological Drug CDMO Product and Services
7.5.4 BioCentriq Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 BioCentriq Recent Developments/Updates
7.5.6 BioCentriq Competitive Strengths & Weaknesses
7.6 FUJIFILM Diosynth Biotechnologies
7.6.1 FUJIFILM Diosynth Biotechnologies Details
7.6.2 FUJIFILM Diosynth Biotechnologies Major Business
7.6.3 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product and Services
7.6.4 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.6.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Details
7.7.2 Thermo Fisher Scientific Major Business
7.7.3 Thermo Fisher Scientific Biological Drug CDMO Product and Services
7.7.4 Thermo Fisher Scientific Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Thermo Fisher Scientific Recent Developments/Updates
7.7.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.8 Recipharm
7.8.1 Recipharm Details
7.8.2 Recipharm Major Business
7.8.3 Recipharm Biological Drug CDMO Product and Services
7.8.4 Recipharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Recipharm Recent Developments/Updates
7.8.6 Recipharm Competitive Strengths & Weaknesses
7.9 Delpharm
7.9.1 Delpharm Details
7.9.2 Delpharm Major Business
7.9.3 Delpharm Biological Drug CDMO Product and Services
7.9.4 Delpharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Delpharm Recent Developments/Updates
7.9.6 Delpharm Competitive Strengths & Weaknesses
7.10 Aenova
7.10.1 Aenova Details
7.10.2 Aenova Major Business
7.10.3 Aenova Biological Drug CDMO Product and Services
7.10.4 Aenova Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Aenova Recent Developments/Updates
7.10.6 Aenova Competitive Strengths & Weaknesses
7.11 Siegfried
7.11.1 Siegfried Details
7.11.2 Siegfried Major Business
7.11.3 Siegfried Biological Drug CDMO Product and Services
7.11.4 Siegfried Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Siegfried Recent Developments/Updates
7.11.6 Siegfried Competitive Strengths & Weaknesses
7.12 WuXi Biologics
7.12.1 WuXi Biologics Details
7.12.2 WuXi Biologics Major Business
7.12.3 WuXi Biologics Biological Drug CDMO Product and Services
7.12.4 WuXi Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 WuXi Biologics Recent Developments/Updates
7.12.6 WuXi Biologics Competitive Strengths & Weaknesses
7.13 Obio Technology
7.13.1 Obio Technology Details
7.13.2 Obio Technology Major Business
7.13.3 Obio Technology Biological Drug CDMO Product and Services
7.13.4 Obio Technology Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Obio Technology Recent Developments/Updates
7.13.6 Obio Technology Competitive Strengths & Weaknesses
7.14 Hepalink
7.14.1 Hepalink Details
7.14.2 Hepalink Major Business
7.14.3 Hepalink Biological Drug CDMO Product and Services
7.14.4 Hepalink Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Hepalink Recent Developments/Updates
7.14.6 Hepalink Competitive Strengths & Weaknesses
7.15 Pharmaron
7.15.1 Pharmaron Details
7.15.2 Pharmaron Major Business
7.15.3 Pharmaron Biological Drug CDMO Product and Services
7.15.4 Pharmaron Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Pharmaron Recent Developments/Updates
7.15.6 Pharmaron Competitive Strengths & Weaknesses
7.16 ChemPartner
7.16.1 ChemPartner Details
7.16.2 ChemPartner Major Business
7.16.3 ChemPartner Biological Drug CDMO Product and Services
7.16.4 ChemPartner Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 ChemPartner Recent Developments/Updates
7.16.6 ChemPartner Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biological Drug CDMO Industry Chain
8.2 Biological Drug CDMO Upstream Analysis
8.3 Biological Drug CDMO Midstream Analysis
8.4 Biological Drug CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biological Drug CDMO Introduction
1.2 World Biological Drug CDMO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biological Drug CDMO Total Market by Region (by Headquarter Location)
1.3.1 World Biological Drug CDMO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biological Drug CDMO Market Size (2018-2029)
1.3.3 China Biological Drug CDMO Market Size (2018-2029)
1.3.4 Europe Biological Drug CDMO Market Size (2018-2029)
1.3.5 Japan Biological Drug CDMO Market Size (2018-2029)
1.3.6 South Korea Biological Drug CDMO Market Size (2018-2029)
1.3.7 ASEAN Biological Drug CDMO Market Size (2018-2029)
1.3.8 India Biological Drug CDMO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological Drug CDMO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biological Drug CDMO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biological Drug CDMO Consumption Value (2018-2029)
2.2 World Biological Drug CDMO Consumption Value by Region
2.2.1 World Biological Drug CDMO Consumption Value by Region (2018-2023)
2.2.2 World Biological Drug CDMO Consumption Value Forecast by Region (2024-2029)
2.3 United States Biological Drug CDMO Consumption Value (2018-2029)
2.4 China Biological Drug CDMO Consumption Value (2018-2029)
2.5 Europe Biological Drug CDMO Consumption Value (2018-2029)
2.6 Japan Biological Drug CDMO Consumption Value (2018-2029)
2.7 South Korea Biological Drug CDMO Consumption Value (2018-2029)
2.8 ASEAN Biological Drug CDMO Consumption Value (2018-2029)
2.9 India Biological Drug CDMO Consumption Value (2018-2029)
3 WORLD BIOLOGICAL DRUG CDMO COMPANIES COMPETITIVE ANALYSIS
3.1 World Biological Drug CDMO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biological Drug CDMO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biological Drug CDMO in 2022
3.2.3 Global Concentration Ratios (CR8) for Biological Drug CDMO in 2022
3.3 Biological Drug CDMO Company Evaluation Quadrant
3.4 Biological Drug CDMO Market: Overall Company Footprint Analysis
3.4.1 Biological Drug CDMO Market: Region Footprint
3.4.2 Biological Drug CDMO Market: Company Product Type Footprint
3.4.3 Biological Drug CDMO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biological Drug CDMO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biological Drug CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biological Drug CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biological Drug CDMO Consumption Value Comparison
4.2.1 United States VS China: Biological Drug CDMO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biological Drug CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biological Drug CDMO Companies and Market Share, 2018-2023
4.3.1 United States Based Biological Drug CDMO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biological Drug CDMO Revenue, (2018-2023)
4.4 China Based Companies Biological Drug CDMO Revenue and Market Share, 2018-2023
4.4.1 China Based Biological Drug CDMO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biological Drug CDMO Revenue, (2018-2023)
4.5 Rest of World Based Biological Drug CDMO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biological Drug CDMO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biological Drug CDMO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biological Drug CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Innovative Drug
5.2.2 Listed Patent Drugs
5.2.3 Biosimilar
5.3 Market Segment by Type
5.3.1 World Biological Drug CDMO Market Size by Type (2018-2023)
5.3.2 World Biological Drug CDMO Market Size by Type (2024-2029)
5.3.3 World Biological Drug CDMO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biological Drug CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.3 Market Segment by Application
6.3.1 World Biological Drug CDMO Market Size by Application (2018-2023)
6.3.2 World Biological Drug CDMO Market Size by Application (2024-2029)
6.3.3 World Biological Drug CDMO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Samsung Biologics
7.1.1 Samsung Biologics Details
7.1.2 Samsung Biologics Major Business
7.1.3 Samsung Biologics Biological Drug CDMO Product and Services
7.1.4 Samsung Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Samsung Biologics Recent Developments/Updates
7.1.6 Samsung Biologics Competitive Strengths & Weaknesses
7.2 Lonza
7.2.1 Lonza Details
7.2.2 Lonza Major Business
7.2.3 Lonza Biological Drug CDMO Product and Services
7.2.4 Lonza Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Lonza Recent Developments/Updates
7.2.6 Lonza Competitive Strengths & Weaknesses
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Details
7.3.2 Boehringer Ingelheim Major Business
7.3.3 Boehringer Ingelheim Biological Drug CDMO Product and Services
7.3.4 Boehringer Ingelheim Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Boehringer Ingelheim Recent Developments/Updates
7.3.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.4 Catalent
7.4.1 Catalent Details
7.4.2 Catalent Major Business
7.4.3 Catalent Biological Drug CDMO Product and Services
7.4.4 Catalent Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Catalent Recent Developments/Updates
7.4.6 Catalent Competitive Strengths & Weaknesses
7.5 BioCentriq
7.5.1 BioCentriq Details
7.5.2 BioCentriq Major Business
7.5.3 BioCentriq Biological Drug CDMO Product and Services
7.5.4 BioCentriq Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 BioCentriq Recent Developments/Updates
7.5.6 BioCentriq Competitive Strengths & Weaknesses
7.6 FUJIFILM Diosynth Biotechnologies
7.6.1 FUJIFILM Diosynth Biotechnologies Details
7.6.2 FUJIFILM Diosynth Biotechnologies Major Business
7.6.3 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product and Services
7.6.4 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.6.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Details
7.7.2 Thermo Fisher Scientific Major Business
7.7.3 Thermo Fisher Scientific Biological Drug CDMO Product and Services
7.7.4 Thermo Fisher Scientific Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Thermo Fisher Scientific Recent Developments/Updates
7.7.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.8 Recipharm
7.8.1 Recipharm Details
7.8.2 Recipharm Major Business
7.8.3 Recipharm Biological Drug CDMO Product and Services
7.8.4 Recipharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Recipharm Recent Developments/Updates
7.8.6 Recipharm Competitive Strengths & Weaknesses
7.9 Delpharm
7.9.1 Delpharm Details
7.9.2 Delpharm Major Business
7.9.3 Delpharm Biological Drug CDMO Product and Services
7.9.4 Delpharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Delpharm Recent Developments/Updates
7.9.6 Delpharm Competitive Strengths & Weaknesses
7.10 Aenova
7.10.1 Aenova Details
7.10.2 Aenova Major Business
7.10.3 Aenova Biological Drug CDMO Product and Services
7.10.4 Aenova Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Aenova Recent Developments/Updates
7.10.6 Aenova Competitive Strengths & Weaknesses
7.11 Siegfried
7.11.1 Siegfried Details
7.11.2 Siegfried Major Business
7.11.3 Siegfried Biological Drug CDMO Product and Services
7.11.4 Siegfried Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Siegfried Recent Developments/Updates
7.11.6 Siegfried Competitive Strengths & Weaknesses
7.12 WuXi Biologics
7.12.1 WuXi Biologics Details
7.12.2 WuXi Biologics Major Business
7.12.3 WuXi Biologics Biological Drug CDMO Product and Services
7.12.4 WuXi Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 WuXi Biologics Recent Developments/Updates
7.12.6 WuXi Biologics Competitive Strengths & Weaknesses
7.13 Obio Technology
7.13.1 Obio Technology Details
7.13.2 Obio Technology Major Business
7.13.3 Obio Technology Biological Drug CDMO Product and Services
7.13.4 Obio Technology Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Obio Technology Recent Developments/Updates
7.13.6 Obio Technology Competitive Strengths & Weaknesses
7.14 Hepalink
7.14.1 Hepalink Details
7.14.2 Hepalink Major Business
7.14.3 Hepalink Biological Drug CDMO Product and Services
7.14.4 Hepalink Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Hepalink Recent Developments/Updates
7.14.6 Hepalink Competitive Strengths & Weaknesses
7.15 Pharmaron
7.15.1 Pharmaron Details
7.15.2 Pharmaron Major Business
7.15.3 Pharmaron Biological Drug CDMO Product and Services
7.15.4 Pharmaron Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Pharmaron Recent Developments/Updates
7.15.6 Pharmaron Competitive Strengths & Weaknesses
7.16 ChemPartner
7.16.1 ChemPartner Details
7.16.2 ChemPartner Major Business
7.16.3 ChemPartner Biological Drug CDMO Product and Services
7.16.4 ChemPartner Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 ChemPartner Recent Developments/Updates
7.16.6 ChemPartner Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biological Drug CDMO Industry Chain
8.2 Biological Drug CDMO Upstream Analysis
8.3 Biological Drug CDMO Midstream Analysis
8.4 Biological Drug CDMO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Biological Drug CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biological Drug CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biological Drug CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biological Drug CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biological Drug CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biological Drug CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biological Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biological Drug CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biological Drug CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biological Drug CDMO Players in 2022
Table 12. World Biological Drug CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biological Drug CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Biological Drug CDMO Player
Table 15. Biological Drug CDMO Market: Company Product Type Footprint
Table 16. Biological Drug CDMO Market: Company Product Application Footprint
Table 17. Biological Drug CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Biological Drug CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biological Drug CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biological Drug CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biological Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biological Drug CDMO Revenue Market Share (2018-2023)
Table 23. China Based Biological Drug CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biological Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biological Drug CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biological Drug CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biological Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biological Drug CDMO Revenue Market Share (2018-2023)
Table 29. World Biological Drug CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biological Drug CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biological Drug CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biological Drug CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biological Drug CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biological Drug CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Samsung Biologics Basic Information, Area Served and Competitors
Table 36. Samsung Biologics Major Business
Table 37. Samsung Biologics Biological Drug CDMO Product and Services
Table 38. Samsung Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Samsung Biologics Recent Developments/Updates
Table 40. Samsung Biologics Competitive Strengths & Weaknesses
Table 41. Lonza Basic Information, Area Served and Competitors
Table 42. Lonza Major Business
Table 43. Lonza Biological Drug CDMO Product and Services
Table 44. Lonza Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Lonza Recent Developments/Updates
Table 46. Lonza Competitive Strengths & Weaknesses
Table 47. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 48. Boehringer Ingelheim Major Business
Table 49. Boehringer Ingelheim Biological Drug CDMO Product and Services
Table 50. Boehringer Ingelheim Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Boehringer Ingelheim Recent Developments/Updates
Table 52. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 53. Catalent Basic Information, Area Served and Competitors
Table 54. Catalent Major Business
Table 55. Catalent Biological Drug CDMO Product and Services
Table 56. Catalent Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Catalent Recent Developments/Updates
Table 58. Catalent Competitive Strengths & Weaknesses
Table 59. BioCentriq Basic Information, Area Served and Competitors
Table 60. BioCentriq Major Business
Table 61. BioCentriq Biological Drug CDMO Product and Services
Table 62. BioCentriq Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. BioCentriq Recent Developments/Updates
Table 64. BioCentriq Competitive Strengths & Weaknesses
Table 65. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 66. FUJIFILM Diosynth Biotechnologies Major Business
Table 67. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product and Services
Table 68. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 70. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 71. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 72. Thermo Fisher Scientific Major Business
Table 73. Thermo Fisher Scientific Biological Drug CDMO Product and Services
Table 74. Thermo Fisher Scientific Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Thermo Fisher Scientific Recent Developments/Updates
Table 76. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 77. Recipharm Basic Information, Area Served and Competitors
Table 78. Recipharm Major Business
Table 79. Recipharm Biological Drug CDMO Product and Services
Table 80. Recipharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Recipharm Recent Developments/Updates
Table 82. Recipharm Competitive Strengths & Weaknesses
Table 83. Delpharm Basic Information, Area Served and Competitors
Table 84. Delpharm Major Business
Table 85. Delpharm Biological Drug CDMO Product and Services
Table 86. Delpharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Delpharm Recent Developments/Updates
Table 88. Delpharm Competitive Strengths & Weaknesses
Table 89. Aenova Basic Information, Area Served and Competitors
Table 90. Aenova Major Business
Table 91. Aenova Biological Drug CDMO Product and Services
Table 92. Aenova Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Aenova Recent Developments/Updates
Table 94. Aenova Competitive Strengths & Weaknesses
Table 95. Siegfried Basic Information, Area Served and Competitors
Table 96. Siegfried Major Business
Table 97. Siegfried Biological Drug CDMO Product and Services
Table 98. Siegfried Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Siegfried Recent Developments/Updates
Table 100. Siegfried Competitive Strengths & Weaknesses
Table 101. WuXi Biologics Basic Information, Area Served and Competitors
Table 102. WuXi Biologics Major Business
Table 103. WuXi Biologics Biological Drug CDMO Product and Services
Table 104. WuXi Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. WuXi Biologics Recent Developments/Updates
Table 106. WuXi Biologics Competitive Strengths & Weaknesses
Table 107. Obio Technology Basic Information, Area Served and Competitors
Table 108. Obio Technology Major Business
Table 109. Obio Technology Biological Drug CDMO Product and Services
Table 110. Obio Technology Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Obio Technology Recent Developments/Updates
Table 112. Obio Technology Competitive Strengths & Weaknesses
Table 113. Hepalink Basic Information, Area Served and Competitors
Table 114. Hepalink Major Business
Table 115. Hepalink Biological Drug CDMO Product and Services
Table 116. Hepalink Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Hepalink Recent Developments/Updates
Table 118. Hepalink Competitive Strengths & Weaknesses
Table 119. Pharmaron Basic Information, Area Served and Competitors
Table 120. Pharmaron Major Business
Table 121. Pharmaron Biological Drug CDMO Product and Services
Table 122. Pharmaron Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Pharmaron Recent Developments/Updates
Table 124. ChemPartner Basic Information, Area Served and Competitors
Table 125. ChemPartner Major Business
Table 126. ChemPartner Biological Drug CDMO Product and Services
Table 127. ChemPartner Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Biological Drug CDMO Upstream (Raw Materials)
Table 129. Biological Drug CDMO Typical Customers
Table 1. World Biological Drug CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biological Drug CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biological Drug CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biological Drug CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biological Drug CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biological Drug CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biological Drug CDMO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biological Drug CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biological Drug CDMO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biological Drug CDMO Players in 2022
Table 12. World Biological Drug CDMO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biological Drug CDMO Company Evaluation Quadrant
Table 14. Head Office of Key Biological Drug CDMO Player
Table 15. Biological Drug CDMO Market: Company Product Type Footprint
Table 16. Biological Drug CDMO Market: Company Product Application Footprint
Table 17. Biological Drug CDMO Mergers & Acquisitions Activity
Table 18. United States VS China Biological Drug CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biological Drug CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biological Drug CDMO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biological Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biological Drug CDMO Revenue Market Share (2018-2023)
Table 23. China Based Biological Drug CDMO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biological Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biological Drug CDMO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biological Drug CDMO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biological Drug CDMO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biological Drug CDMO Revenue Market Share (2018-2023)
Table 29. World Biological Drug CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biological Drug CDMO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biological Drug CDMO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biological Drug CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biological Drug CDMO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biological Drug CDMO Market Size by Application (2024-2029) & (USD Million)
Table 35. Samsung Biologics Basic Information, Area Served and Competitors
Table 36. Samsung Biologics Major Business
Table 37. Samsung Biologics Biological Drug CDMO Product and Services
Table 38. Samsung Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Samsung Biologics Recent Developments/Updates
Table 40. Samsung Biologics Competitive Strengths & Weaknesses
Table 41. Lonza Basic Information, Area Served and Competitors
Table 42. Lonza Major Business
Table 43. Lonza Biological Drug CDMO Product and Services
Table 44. Lonza Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Lonza Recent Developments/Updates
Table 46. Lonza Competitive Strengths & Weaknesses
Table 47. Boehringer Ingelheim Basic Information, Area Served and Competitors
Table 48. Boehringer Ingelheim Major Business
Table 49. Boehringer Ingelheim Biological Drug CDMO Product and Services
Table 50. Boehringer Ingelheim Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Boehringer Ingelheim Recent Developments/Updates
Table 52. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 53. Catalent Basic Information, Area Served and Competitors
Table 54. Catalent Major Business
Table 55. Catalent Biological Drug CDMO Product and Services
Table 56. Catalent Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Catalent Recent Developments/Updates
Table 58. Catalent Competitive Strengths & Weaknesses
Table 59. BioCentriq Basic Information, Area Served and Competitors
Table 60. BioCentriq Major Business
Table 61. BioCentriq Biological Drug CDMO Product and Services
Table 62. BioCentriq Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. BioCentriq Recent Developments/Updates
Table 64. BioCentriq Competitive Strengths & Weaknesses
Table 65. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 66. FUJIFILM Diosynth Biotechnologies Major Business
Table 67. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product and Services
Table 68. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 70. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 71. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 72. Thermo Fisher Scientific Major Business
Table 73. Thermo Fisher Scientific Biological Drug CDMO Product and Services
Table 74. Thermo Fisher Scientific Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Thermo Fisher Scientific Recent Developments/Updates
Table 76. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 77. Recipharm Basic Information, Area Served and Competitors
Table 78. Recipharm Major Business
Table 79. Recipharm Biological Drug CDMO Product and Services
Table 80. Recipharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Recipharm Recent Developments/Updates
Table 82. Recipharm Competitive Strengths & Weaknesses
Table 83. Delpharm Basic Information, Area Served and Competitors
Table 84. Delpharm Major Business
Table 85. Delpharm Biological Drug CDMO Product and Services
Table 86. Delpharm Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Delpharm Recent Developments/Updates
Table 88. Delpharm Competitive Strengths & Weaknesses
Table 89. Aenova Basic Information, Area Served and Competitors
Table 90. Aenova Major Business
Table 91. Aenova Biological Drug CDMO Product and Services
Table 92. Aenova Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Aenova Recent Developments/Updates
Table 94. Aenova Competitive Strengths & Weaknesses
Table 95. Siegfried Basic Information, Area Served and Competitors
Table 96. Siegfried Major Business
Table 97. Siegfried Biological Drug CDMO Product and Services
Table 98. Siegfried Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Siegfried Recent Developments/Updates
Table 100. Siegfried Competitive Strengths & Weaknesses
Table 101. WuXi Biologics Basic Information, Area Served and Competitors
Table 102. WuXi Biologics Major Business
Table 103. WuXi Biologics Biological Drug CDMO Product and Services
Table 104. WuXi Biologics Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. WuXi Biologics Recent Developments/Updates
Table 106. WuXi Biologics Competitive Strengths & Weaknesses
Table 107. Obio Technology Basic Information, Area Served and Competitors
Table 108. Obio Technology Major Business
Table 109. Obio Technology Biological Drug CDMO Product and Services
Table 110. Obio Technology Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Obio Technology Recent Developments/Updates
Table 112. Obio Technology Competitive Strengths & Weaknesses
Table 113. Hepalink Basic Information, Area Served and Competitors
Table 114. Hepalink Major Business
Table 115. Hepalink Biological Drug CDMO Product and Services
Table 116. Hepalink Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Hepalink Recent Developments/Updates
Table 118. Hepalink Competitive Strengths & Weaknesses
Table 119. Pharmaron Basic Information, Area Served and Competitors
Table 120. Pharmaron Major Business
Table 121. Pharmaron Biological Drug CDMO Product and Services
Table 122. Pharmaron Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Pharmaron Recent Developments/Updates
Table 124. ChemPartner Basic Information, Area Served and Competitors
Table 125. ChemPartner Major Business
Table 126. ChemPartner Biological Drug CDMO Product and Services
Table 127. ChemPartner Biological Drug CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 128. Global Key Players of Biological Drug CDMO Upstream (Raw Materials)
Table 129. Biological Drug CDMO Typical Customers
LIST OF FIGURES
Figure 1. Biological Drug CDMO Picture
Figure 2. World Biological Drug CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biological Drug CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biological Drug CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biological Drug CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Biological Drug CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biological Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biological Drug CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biological Drug CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biological Drug CDMO Markets in 2022
Figure 27. United States VS China: Biological Drug CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biological Drug CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biological Drug CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biological Drug CDMO Market Size Market Share by Type in 2022
Figure 31. Innovative Drug
Figure 32. Listed Patent Drugs
Figure 33. Biosimilar
Figure 34. World Biological Drug CDMO Market Size Market Share by Type (2018-2029)
Figure 35. World Biological Drug CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Biological Drug CDMO Market Size Market Share by Application in 2022
Figure 37. Pharmaceutical Company
Figure 38. Biotechnology Company
Figure 39. Biological Drug CDMO Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Biological Drug CDMO Picture
Figure 2. World Biological Drug CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biological Drug CDMO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biological Drug CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biological Drug CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biological Drug CDMO Revenue (2018-2029) & (USD Million)
Figure 13. Biological Drug CDMO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biological Drug CDMO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biological Drug CDMO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biological Drug CDMO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biological Drug CDMO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biological Drug CDMO Markets in 2022
Figure 27. United States VS China: Biological Drug CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biological Drug CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biological Drug CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biological Drug CDMO Market Size Market Share by Type in 2022
Figure 31. Innovative Drug
Figure 32. Listed Patent Drugs
Figure 33. Biosimilar
Figure 34. World Biological Drug CDMO Market Size Market Share by Type (2018-2029)
Figure 35. World Biological Drug CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Biological Drug CDMO Market Size Market Share by Application in 2022
Figure 37. Pharmaceutical Company
Figure 38. Biotechnology Company
Figure 39. Biological Drug CDMO Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
